Repligen (RGEN) Cash from Operations (2010 - 2026)
Repligen's (RGEN) quarterly Cash from Operations came in at $32.8 million in Q2 2026, up 14.53% year-over-year from $28.6 million in Q2 2025, and up 15.8% quarter-over-quarter from $28.3 million in Q1 2026.
Analysis
Repligen (RGEN) Cash from Operations (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Cash from Operations for 17 consecutive years, with $32.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Operations rose 14.53% year-over-year to $32.8 million in Q2 2026; TTM through Jun 2026 was $134.9 million, a 2.08% increase from a year earlier, with the FY2025 full-year figure at $117.4 million, down 33.06% from the prior year.
- Cash from Operations was $32.8 million for Q2 2026 at Repligen, up from $28.3 million in the prior quarter.
- Over five years, Cash from Operations peaked at $61.9 million in Q4 2022 and troughed at $11.2 million in Q1 2023.
- A 5-year average of $35.5 million and a median of $36.8 million in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations soared 300.82% in 2024 and sank 66.44% in 2025, its largest moves.
- Over 5 years, Cash from Operations stood at $61.9 million in 2022, then slumped by 53.03% to $29.1 million in 2023, then surged by 34.79% to $39.2 million in 2024, then tumbled by 34.39% to $25.7 million in 2025, then advanced by 27.47% to $32.8 million in 2026.
- The last three Cash from Operations figures came in at $32.8 million (Q2 2026), $28.3 million (Q1 2026), and $25.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 2.13 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 1.53 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 519.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 201.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 191.94 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 95.42 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 98.70 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 32.77 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 16.97 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -77.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.77 Mn |
| Mar 31, 2026 | 28.30 Mn |
| Dec 31, 2025 | 25.70 Mn |
| Sep 30, 2025 | 48.10 Mn |
| Jun 30, 2025 | 28.61 Mn |
| Mar 31, 2025 | 15.01 Mn |
| Dec 31, 2024 | 39.18 Mn |
| Sep 30, 2024 | 49.32 Mn |
| Jun 30, 2024 | 42.19 Mn |
| Mar 31, 2024 | 44.71 Mn |
| Dec 31, 2023 | 29.07 Mn |
| Sep 30, 2023 | 39.23 Mn |
| Jun 30, 2023 | 34.47 Mn |
| Mar 31, 2023 | 11.15 Mn |
| Dec 31, 2022 | 61.88 Mn |
| Sep 30, 2022 | 41.37 Mn |
| Jun 30, 2022 | 45.72 Mn |
| Mar 31, 2022 | 23.11 Mn |
| Dec 31, 2021 | 49.62 Mn |
| Sep 30, 2021 | 22.48 Mn |